ARKG US · ETF FactsheetARK Genomic Revolution ETF
Generated by Nukoud (nukoud.com) for informational purposes only — not investment advice, a recommendation, or an offer to buy or sell any security. Data is sourced from third-party providers and may be delayed or inaccurate. Past performance is not indicative of future results.
ARK Genomic Revolution ETF
Exchange-Traded FundTechnical indicators
End of dayMoving averages
- 20-day SMA
- 48.9950 USD-5.56%Bearish
- 50-day SMA
- 49.7328 USD-6.96%Bearish
- 100-day SMA
- 46.1669 USD+0.22%Bullish
- 200-day SMA
- 38.0089 USD+21.73%Bullish
- 12-day EMA
- 48.3648 USD-4.33%Bearish
- 26-day EMA
- 49.1277 USD-5.82%Bearish
Oscillators
Sign in for the oscillators
RSI, MACD, Bollinger position and volatility for this fund — plus signal changes across every listing Nukoud tracks. A free account covers it.
Checking your session…Range & bands
Calculated from end-of-day closing prices. They describe how this fund has already traded, not what it will do next, and are information only — not advice.
About this fund
ARK Genomic Revolution ETF (ARKG) is a Thematic and Technology ETF managed by ARK Investment Management LLC, listed on Cboe BZX U.S. Equities Exchange, quoted in USD. It charges a 0.75% net expense ratio and holds $1.97B in assets as of Nov 10, 2026. The fund launched on Oct 31, 2014.
- Benchmark
- NASDAQ Health CareGross return, EUR
- Distribution
- Annually
- AUM
- $1.97B
- Expense Ratio
- 0.75%
- Yield (12-mo)
- —
- Morningstar Rating
- Benchmark
- NASDAQ Health Care
- 52-Week Range
- Avg Daily Vol
- 4.89M
- Inception
- Oct 31, 2014
Risk metrics
vs benchmark NASDAQ Health Care · Gross return, EUR
3-year risk statistics are not currently available for this fund.
Risk statistics are 3-year, month-end-based.
Trailing returns
As of Nov 10, 2026Calendar-year returns
Morningstar daily closesTrading & liquidity
as of Nov 10, 2026
Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.
Top 10 holdings
Source: MorningstarFees & expenses
Classification
- Category
- Equity – Sector
- Asset class
- Equity
- Strategy
- Active
- Themes
- Genomics
- Sector
- Health Care
- Issuer
- ARK Investment Management LLC
- Branding
- ARK
Similar ETFs
Funds sharing the same category or exposures.
- GNOMUS$105.76M0.500%+43.65%
Global X Genomics & Biotechnology ETF
Same category · Same sector · genomics
- HELXUS$34.82M0.500%+16.22%
Franklin Genomic Advancements ETF
Same category · Same sector · genomics
- XLVUS$50.35B0.080%+23.52%
State Street® Health Care Select Sector SPDR® ETF
Same category · Same sector
- IBBUS$11.34B0.440%+28.80%
iShares Biotechnology ETF
Same category · Same sector
- VGTUS$167.05B0.090%+17.70%
Vanguard Information Technology Index Fund
Same group
- XLKUS$114.21B0.080%+17.74%
State Street® Technology Select Sector SPDR® ETF
Same group
Frequently asked questions
- What is ARKG's expense ratio?
- ARK Genomic Revolution ETF charges a net expense ratio of 0.750%.
- How large is ARK Genomic Revolution ETF?
- ARKG holds $1.97B in assets under management.
- What index does ARKG track?
- ARK Genomic Revolution ETF tracks NASDAQ Health Care as its primary benchmark.
- When did ARKG launch?
- ARK Genomic Revolution ETF launched on October 31, 2014.
- What currency does ARKG trade in?
- ARKG trades in USD on Cboe BZX U.S. Equities Exchange.
Fund information
- Ticker
- ARKG
- Performance ID
- 0P0000ZGO9
- Inception
- Oct 31, 2014
- Domicile
- USA
- Base currency
- USD
- Listing currency
- USD
- AUM
- $1.97B
- Avg daily volume (3M)
- 4.89M
Charting by TradingView.
